Merck | MRK - Gewinn Vor Steuern

Aktienkurs
104.05
Täglich Wechseln
-3.30 -3.07%
Monatlich
-17.36%
Jährlich
-20.81%
Q1 Prognose
104.71




Gewinn Vor Steuern Veränderung Datum
Adidas EUR 650M 162M 2025-09
Adyen EUR 633.48M 290.9M 2025-06
Akzo Nobel EUR 179M 10M 2025-06
Alcon AG USD 264M 19M 2025-12
Amadeus IT EUR 468.3M 16.5M 2025-09
Amarin USD -852K 7.26M 2025-12
AstraZeneca USD 3.24B 117M 2025-09
BASF EUR 35M 109M 2025-09
Bayer EUR -1.16B 735M 2025-09
Beiersdorf EUR 408.5M 43.5M 2025-06
Covestro EUR -9M 20M 2025-09
Danone EUR 1.73B 133M 2024-12
Fresenius EUR 601M 122M 2025-12
Fresenius Medical Care EUR 508.46M 105.89M 2025-12
Galapagos EUR -221.49M 117.07M 2025-09
Genmab DKK 55M 427M 2025-12
Givaudan CHF 642M 292M 2024-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Infineon EUR 338M 322M 2025-12
Linde USD 2.42B 72M 2025-09
Lonza CHF 624M 197M 2024-12
Merck EUR 1.29B 458.1M 2025-09
Novartis USD 4.64B 445M 2025-12
Philips EUR 275M 62M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
UCB EUR 789M 427M 2025-06